Girlfriend Encourages Boyfriend To Commit Suicide Before His Graduation

https://goodyfeed.com/girlfriend-encourages-boyfriend-to-commit-suicide-before-his-graduation/

n 2014, the news that Michelle Carter encouraged her boyfriend, Conrad Roy to kill himself through dozens of text messages shocked the world because she took advantage of his mental distress instead of helping him through it.

This time, 21-year-old Inyoung You in USA was recently indicted for having caused the suicide of her boyfriend, Alexander Urtula, a 21-year-old Boston College student.

Backstory

According to CBS News, prosecutors said that You had “complete and total control” over her boyfriend. Suffolk District Attorney Rachael Rollins said that throughout the 18 months that the couple was together, Urtula was subjected to verbal, physical and psychological abuse. This was later proven to be true by both their family members and classmates.

You allegedly manipulated Urtula and controlled him by threatening him that she would commit self-harm if he didn’t listen to what she said. The abuse then became “more frequent, more powerful and more demeaning” closer to his death.

She clearly pushed him into a corner and made sure that he stayed there; classic power play.

Prior to Urtula’s suicide, the couple had an exchange of more than 75,000 text messages, with 47,000 of them being from You.

According to Rollins, You knew she had the upper hand in this relationship and had control over Urtula’s “spiralling depression and suicidal thoughts brought on by her abuse, yet she persisted in continuing to encourage him to take his own life”.

What kind of monster does this?

What Happened

On 20 May, the day of his Boston College graduation, Urtula decided to end his life and later jumped to his death from a parking garage in Boston.

While this happened, his family who travelled down to Boston from New Jersey to see him graduate waited for him at the ceremony.

It was supposed to be a joyous occasion for them to celebrate his achievements. Little did they know…

Rollins said that You was in knowledge of where Urtula was because she could track his location on her phone and they believe that she was apparently “present” when he killed himself. However, it is not known whether they had interactions right before his death.

This is some sick twisted love. To think that he suffered through 18 months of torture before he finally decided that it was enough. 

Despite knowing that he was already unstable because of the abuse he suffered from her, she continued to abuse him and told him that he should kill himself. Rollins even announced that there were hundreds of messages from You encouraging him to commit suicide.

What’s Going To Happen To Her?

You is currently in South Korea and authorities are fairly certain that she will return soon to face her charges.

Hopefully, justice will be served and she pays for her mistakes. Urtula’s family deserves at least that much after losing their son.

If you know anyone who has suicidal thoughts or is someone who is getting domestic abuse, please do not hesitate to reach out to Samaritans of Singapore at their 24-hour hotline at 1800 221 4444 or the AWARE helpline at 1800 777 5555.

Why am I posting this ?… while no healthcare professional will encourage a pt to commit suicide…HOWEVER… doctors, pharmacists, nurses are consider “learned professionals” and they know or should know that reducing, eliminating a pt’s medications… especially throwing them into cold turkey withdrawal… that this could push some pts to suicide.

As things are progressing within and around the “opiate crisis” …. just how long before one of these healthcare professionals are charged AND CONVICTED of assisting suicide or involuntary manslaughter ?  What if the healthcare professional is just following the corporation’s edict as to what they will provide or not provide to any given patient.

Whatever policies or edicts that comes from the corporation’s HQ that involves the practice of medicine… can the execs who have promulgated these edicts be held responsible for the adverse health outcomes of any particular pts or groups of pts.

Here is a letter that was sent out by Kaiser this month to a untold number of pts. This would suggest that this is a “group” of pts that are probably considered covered under the Americans with Disability Act. Typically this is what class action law firms look for… a large number of people being harmed by a corporation that is well insured and/or has “deep pockets” – OR BOTH.

The “clock” could be “ticking” on a lot of healthcare corporations who have elected to establish corporate policies that are basically deny care to pts dealing with specific health conditions.

Once the first healthcare corporation is found guilty and/or settles… it could be the first domino falling.. in what could be a very long line of dominoes.

Filed under: General Problems | 3 Comments »

Rx Open is activated for CA. The map was last updated Wednesday, October 30, at 3:05 pm

About Rx Open

Filed under: General Problems | Leave a Comment »

Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-pharmaceuticals-initiates-voluntary-nationwide-recall-one-lot-alprazolam-tablets-usp-c-iv-05

Summary

Company Announcement

Mylan Pharmaceuticals Inc. is conducting a voluntary nationwide recall of one lot (see table below) of Alprazolam Tablets, USP C-IV 0.5 mg, to the consumer/user level. This lot is being recalled due to the potential presence of foreign substance. Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out. To date, Mylan has not received any adverse events related to this batch.

Alprazolam Tablets are indicated for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia.

Alprazolam Tablets, USP C-IV 0.5 mg, are packaged in bottles of 500. This batch was distributed in the U.S. between July 2019 and August 2019. The recalled lot is as follows:

Mylan has notified its distributors and customers by letter and is arranging for return of all recalled products. Following are actions for wholesalers, retailers and consumers:

• Wholesaler: Immediately examine your inventory, quarantine and discontinue distribution of these lots. In addition, if you have further distributed the product, please identify your retail level customers and provide a list of customers via Microsoft excel file to mylan5924@stericycle.com within 10 business days. Stericycle will notify your retail level customers that received the affected batches.
• Retailer: Immediately examine your inventory, quarantine and discontinue distribution of these lots. Additionally, if you have further distributed the product, please identify the consumer and notify them immediately of this product recall. The consumer should be instructed to contact Stericycle at 1-888-843-0255 for the documentation packet to return the product.

• Consumer: Please contact Stericycle at 1-888-843-0255 for the documentation packet to return product to Stericycle.

Consumers with questions regarding this recall can contact Mylan Customer Relations at 800.796.9526 or customer.service@mylan.com, Monday through Friday from 8 a.m. – 5 p.m. EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online
• Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration

Filed under: General Problems | 1 Comment »

Tania Burgess for America

https://www.facebook.com/taniaburgessforcongress/

Filed under: General Problems | 1 Comment »

There has been some discussion in a few FB groups in particular about creating and funding a “legal defense fund”. To address the issue that many in the chronic pain community is dealing with is a multi-faceted problem. Federal rules/laws, state rules/laws and healthcare corporations (Insurance/PBM, healthcare corporations, chain pharmacies, CDC guidelines, and numerous interpretations and implementations of those guidelines.

Below is a very recent example of how some of these healthcare corporations are making policies that are going to adversely impacting the quality of life of many pts, many of whom are covered by the Americans with Disability Act.

What we are seeing a classic lawsuit tactics to force defendants into settling.  The first example was the tactics of several state AG’s against the company that first brought out Zohydro ER – a long acting Hydrocodone – no Acetaminophen – and did not contain an abuse deterrent.  The company was sued in a number of different states… forcing the company to hire law firms in each of those states to defend themselves.  This was a fairly young company and Zohydro was their only product… needless to say… the cost of defending themselves in all those states and paying for all those different law firms… caused them to file for bankruptcy.

We are seeing the same thing going on with the lawsuits against various pharmas, wholesaler and chain pharmacies over the opiate crisis.  Numerous cities, counties and states have filed lawsuits. I have seen where the number of plaintiffs being listed in the THOUSANDS.  It is all a “legal game” to encourage the plaintiffs to SETTLE .. rather than go thru all the costs of defending all of these lawsuits in all of these different states.  It is claimed that there is some 100 million chronic pain pts.. and that 80% are struggling financially… that leaves 20 million who are not struggling financially… and getting a $10/month donation from each of those represents a potential 200 million/month cash flow… even getting 5% to contribute would potentially generate 10 million/month.

The chronic pain community needs a law firm, PR firm and a lobbyist firm on the job. Since most/all chronic pain pts are considered a covered entity under the Americans with Disability Act and Civil Rights Act…

While you can’t sue the government, there is nothing that prevents the community from challenging the various laws/rules/regulations that are being passed by Fed/state legislatures. There is nothing in our legislative system that guarantees that any bill signed into law is constitutional, but our system is set up that as long as a law is on the books .. it can be enforced… until someone challenges the constitutionality in our court system and it is declared unconstitutional.

The DEA has its own PRESS RELEASE MACHINE  https://www.dea.gov/press-releases   shouldn’t the chronic pain community have it own PRESS RELEASE MACHINE…?  While it is great that chronic pain pts occasionally gets a some press, but occasional press in various markets around the country … is no more than a “flash in the pan”

The question has to be asked, why are all of these various entities discriminating against chronic pain pts ?  Could it be that they are being encouraged – or intimidated by the DEA – to do so… and to date … they have suffered no adverse consequences.  Some of these entities – Insurance/PBM/HMO – actually makes more profit from denying care and not having to pay for that care.  Prescribers and chain pharmacies are less at risk of running afoul of the DEA and avoiding potential fines.

I recently made this post  97% of Congress voted for this law designed to DENY CHRONIC PAIN PTS APPROPRIATE THERAPY       so this Congress has routinely voted for bills along party long, except when it came to voting on denying chronic pain pts adequate pain management and increase funding for the treatment of substance abusers.  If the chronic pain community had a lobbyist firm ON THE JOB in DC… this bill may have not gotten passed and signed into law.

Will the chronic pain community finally come together or remain on the side lines and continue to suffer ?

Filed under: General Problems | 9 Comments »

Filed under: General Problems | 1 Comment »

Often Mistaken But Never in Doubt. Dr. Debra Houry and CDC Guidelines on Opioid Prescription in Chronic Pain

https://www.acsh.org/news/2019/10/28/often-mistaken-never-doubt-dr-debra-houry-and-cdc-guidelines-opioid-prescription-chronic-pain-14363

What I have not seen – and I may have missed it – that no one has came out and questioned – or validated – that CDC actually had the statutory authority to generate and publish these guidelines. The CDC primary charge is to deal with communicable diseases and the treatment and/or prevention.  Subjective and/or mental health diseases or neither communicably nor preventable.

Filed under: General Problems | Leave a Comment »

From: opioid-safety-and-naloxone-network@googlegroups.com <opioid-safety-and-naloxone-network@googlegroups.com> On Behalf Of Daniel Raymond
Sent: Monday, October 28, 2019 2:49 PM
To: OSNN <opioid-safety-and-naloxone-network@googlegroups.com>
Subject: [OSNN] Fwd: Responses Due by COB Wed., 10/30: CSOO Letter to E&C Re CARE Act of 2019

Hi everyone –

Kelly Corredor with the American Society of Addiction Medicine is asking for organizational sign-ons to the attached letter, encouraging the House Energy & Commerce Committee to move forward the Comprehensive Addiction Resources Emergency (CARE) Act. The CARE Act would provide $100 billion to address the overdose epidemic over the next 10 years, along with a provision for direct federal price negotiations with naloxone manufacturers to broaden access to and availability of naloxone.

Rep. Elijah Cummings introduced the CARE Act in the House and was its primary champion on the House side (Sen. Warren introduced the Senate version); with his untimely passing, there is a need to ensure that the CARE Act remains on the agenda for Congress.

If your organization can sign on to this letter, please contact Kelly directly at kcorredor@ASAM.org by 5 pm ET on Wednesday, 10/30.

Best,

Daniel

Daniel Raymond
Deputy Director of Planning and Policy
Harm Reduction Coalition
22 West 27th Street, 5th Floor
New York, NY 10001

Direct: (212) 377-9121
Mobile: (646) 283-8929
Fax: (212) 213-6582
raymond@harmreduction.org
www.harmreduction.org

October __, 2019

Dear Chairman Pallone and Ranking Member Walden,

The undersigned organizations in the Coalition to Stop Opioid Overdose (CSOO) and other undersigned organizations are writing today to voice our support for the Comprehensive Addiction Resources Emergency (CARE) Act of 2019. With the recent and tragic passing of its lead House sponsor, Representative Elijah Cummings, only with your leadership, can we keep the ideas in this legislation alive.

CSOO is a coalition of diverse organizations united around common policy goals to reduce opioid overdose deaths. CSOO members aim to elevate the national conversation around opioid overdose and work to enact meaningful and comprehensive policy changes that support evidence-based prevention, treatment, harm reduction, and recovery support services.

As we know too well, the morbidity and mortality statistics related to addiction, and in particular addiction involving opioid use, are astounding. In 2017, there were a record 70,237 drug overdose deaths in the United States, two-thirds of which have been linked to opioids.ⁱ Moreover, for three years in a row, life expectancy in the United States declined largely because of rising drug overdose deaths.ⁱⁱ While preliminary data indicates that drug overdose deaths may have slightly declined last year,ⁱⁱⁱ drug overdose deaths remain at historic highs, and synthetic opioids continue to pose a significant threat to life.^iv Given these alarming statistics, we need your leadership to pass legislation like the CARE Act of 2019, which provides bold actions that would help to turn the tide of our country’s addiction and overdose epidemic and save lives.

Modeled directly on the Ryan White Act, the CARE Act of 2019 would provide $100 billion in federal funding over the next ten years to states, local governments, and other organizations and institutions to support federal research and programs to prevent drug use while expanding access to prevention, harm reduction, addiction treatment, mental health services, and recovery support services. This level of authorized funding is critical in order to build comprehensive systems that are both effective and sustainable. The CARE Act would also incent systemic changes to facilitate adoption of evidence-based

practices and grow our mental health and addiction services workforce. For example, the bill would facilitate the implementation of nationally recognized level of care standards for addiction treatment

programs and new standards for recovery residences and improve training for healthcare professionals who care for patients with mental health and substance use disorders in communities across the US.

These provisions, among the others in the bill, are urgently needed and will move us closer to a future where all Americans living with mental health and/or substance use disorders are able to receive the high-quality care they need and deserve.

We would like to thank you for considering the CARE Act of 2019, and we look forward to working with you to secure its passage or the passage of substantially similar legislation.

Sincerely,

American Society of Addiction Medicine

*Not a CSOO member 

Filed under: General Problems | 3 Comments »

Filed under: General Problems | 3 Comments »

23 Seniors Died After Receiving Flu Shot Sold by Pharmacies

https://healthimpactnews.com/2013/23-seniors-died-after-receiving-this-years-flu-shot-sold-by-pharmacies/

Package insert for Fluzone flu vaccine marketed to seniors reveals 23 seniors died during drug trial

The annual marketing campaign pushing people to receive flu vaccinations is in full force. CVS Pharmacies is offering a 20% off shopping pass if you purchase a flu vaccine.

As you can see in the screen shot above, taken from the CVS website, senior citizens over the age of 65 are being targeted to get the “high-dose” flu vaccine.

The FAQ at the CVS website defines the “high-dose” flu vaccine: “Containing four times the amount of antigen (the part of the vaccine that causes the body to produce antibody) in regular flu shots, high-dose flu shots, along with the additional antigen produced, are intended to create a stronger immune response.”

The name of this flu vaccine that is marketed for seniors is called “Fluzone.” You can find it being marketed to seniors at all the major pharmacies in the United States.

Package inserts for flu vaccines show a multitude of side effects, including death, and yet they are marketed the same as over-the-counter drugs with no prescription needed. Why?

Because in the United States vaccines enjoy complete immunity from lawsuits in the market place. If you are injured or die from a vaccine, you or your family cannot sue the manufacturer of the vaccine. This law enacted by Congress, was upheld by the U.S. Supreme Court in 2011.

Therefore, they are marketed with the same marketing techniques as any other high-profit product. With the baby boomer generation moving into their senior years, today’s seniors are seen as an especially lucrative market.

So financial incentives like discounts on other products, as CVS is doing, is quite common in order to boost vaccine sales.

Walgreens has a different program that especially boosts sales of vaccines:

While vaccine rates in the U.S. among children are close to 90%, rates in other parts of the world (where pharmaceutical companies do not have immunity from the law for adverse effects) are much lower. So, in partnership with Walgreens, a non-profit organization (Shot@Life) buys up the vaccines and sends them to these countries for free (who doesn’t want something for free, especially when you live in a poor country??)

This is a brilliant marketing plan for the pharmaceutical companies, as the U.S. government gives the organization buying the vaccines non-profit status, allowing them to receive tax deductible donations to pay for the vaccines. Walgreens is probably a contributor to the program as a tax write off.

With legal immunity to market dangerous products, don’t expect those doing the marketing and making the profits to warn you of the side effects. You need to find this information yourself, usually from the Internet.

For those pro-vaccine forces that warn people how dangerous it is to get information from the Internet, the information we are about to share is directly from the FDA website (at least at the time of this writing – they have been known to remove items from their website if it gets too much publicity and makes them look bad), and you can look it up yourself.

The high-dose Fluzone vaccine being marketed this flu season to seniors, which has four times the amount of antigens that the regular flu shot has, as well as the non-high dose version, had 23 seniors die during drug trials.

The package insert for the high-dose Fluzone flu vaccine is found here (for now).

In the section documenting adverse effects, this is what is written:

Within 6 months post-vaccination, 156 (6.1%) Fluzone High-Dose recipients and 93 (7.4%)  Fluzone recipients experienced a serious adverse event. No deaths were reported within 28 days post-vaccination. A total of 23 deaths were reported during the period Day 29–180 post-vaccination: (0.6%) among Fluzone High-Dose recipients and 7 (0.6%) among Fluzone 1 recipients. The majority of these participants had a medical history of cardiac, hepatic, neoplastic, renal, and/or respiratory diseases. No deaths were considered to be caused by vaccination.

This statement stating that 23 seniors died, which really should be headline news but is buried in a package insert on the FDA website, begs several questions:

1. By what basis can they conclude that “No deaths were considered to be caused by vaccination”??

2. If, as it is implied, the majority of these 23 deaths were caused by pre-existing conditions, why were there no deaths in the first 28 days? Shouldn’t the deaths, if not attributable to the vaccine but pre-existing conditions, be equally spread out through all time periods?

3. How does the medical history for these 23 seniors compare to the medical history of those who did not die? Were there any significant differences? The range of symptoms given in the package insert can very well cover almost all seniors during the flu season. And what about those who died that were not among the “majority” who had these pre-existing conditions? A majority could simply be 12 out of the 23.

Besides death, which is just one “serious adverse event,” there were 226 other “serious” adverse events, for a total of 249 serious adverse events, out of only 3,833 participants.

If this does not constitute a dangerous drug that should probably not even be on the market, then I don’t know what does. And yet, it is sold to unsuspecting seniors and others like candy at these drug stores.

One of these other adverse side effects (besides death) is Guillain-Barré syndrome, which has symptoms similar to polio. If you are brought into an emergency room with the paralyzing effects of Guillain-Barré syndrome (GBS), the first question the doctors will ask you is if you just received the flu shot. Read one story here of how one man went from being able to bench-press 275 pounds to struggling how to walk after receiving last year’s flu shot: Miami Man Contracts Guillain-Barré Syndrome, Nearly Dies After Getting Flu Shot. Also, if you look at the majority of damages being paid out to those damaged from vaccines in the U.S. Vaccine Court, Guillain-Barré syndrome from the flu vaccine is #1, and almost equals all other awards for damages combined. (See: Flu Shot Causes Polio-like Guillain-Barré Syndrome: Are Rates Higher Than the Government Admits?)

The CDC would like you to believe that the risk of GBS from the flu shot is only one out of one million. But if that is the case, why is there a warning on package inserts of flu vaccines, and why is it the first question EMTs ask when dealing with GBS emergencies?

The package insert for Fluzone states: “If Guillain-Barré syndrome (GBS) has occurred within 6 weeks of previous influenza vaccination, the decision to give Fluzone High-Dose should be based on careful consideration of the potential benefits and risks.”

I wonder how many vaccine sales people at these pharmacies give “careful consideration” to this adverse side effect, or any others, before injecting you?

Be informed this flu season! Educate yourself before vaccinating!

Thanks to ExperimentalVaccines for pointing out this package insert information on YouTube.

Leaving a lucrative career as a nephrologist (kidney doctor), Dr. Suzanne Humphries is now free to actually help cure people.

In this autobiography she explains why good doctors are constrained within the current corrupt medical system from practicing real, ethical medicine.

One of the sane voices when it comes to examining the science behind modern-day vaccines, no pro-vaccine extremist doctors have ever dared to debate her in public.

Filed under: General Problems | 4 Comments »